Onconetix agrees to acquire Realbotix robotics subsidiary
Realbotix Corp. signed a definitive all-stock agreement for Nasdaq-listed Onconetix to acquire its Realbotix, LLC robotics subsidiary.
Evidence notes
- The definitive agreement was signed on February 11, 2026 and announced the following day.
- Onconetix agreed to issue shares for 100% of Realbotix, LLC, including its robotics and AI teams and related patents.
- The transaction remained subject to exchange, shareholder and closing approvals and was expected to close before the end of the third quarter.
Company context
Pennsylvania developer of secure telerobotics and industrial remote-access systems.